Lite Strategy, Inc.

LITS Nasdaq CIK: 0001262104

Company Information

Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 9920 PACIFIC HEIGHTS BLVD, SAN DIEGO, CA, 92121
Mailing Address 9920 PACIFIC HEIGHTS BLVD, SAN DIEGO, CA, 92121
Phone 858-369-7100
Fiscal Year End 0630
EIN 510407811

Financial Overview

FY2025 FY

$65.30M
Revenue
$17.78M
Net Income
$8.36M
Total Liabilities
$33.02M
Stockholders' Equity

Recent SEC Filings

Form Type Date Filed Document
4 Insider stock transaction report February 12, 2026 View on SEC
8-K Current report of material events February 12, 2026 View on SEC
DEF 14A Definitive proxy statement December 30, 2025 View on SEC
8-K Current report of material events December 30, 2025 View on SEC
SCHEDULE 13G/A Passive ownership amendment December 22, 2025 View on SEC
4 Insider stock transaction report December 22, 2025 View on SEC
4 Insider stock transaction report December 22, 2025 View on SEC
8-K Current report of material events December 5, 2025 View on SEC
8-K/A Current report amendment November 20, 2025 View on SEC
4 Insider stock transaction report November 20, 2025 View on SEC

Annual Reports

10-K September 26, 2025
  • Launched LiteAI, an AI tool automating repetitive tasks (customer favorite).
  • Added 1,200 new clients, mostly mid-sized companies.
View Analysis

Material Events

8-K Leadership Change December 30, 2025
Medium Impact
  • Lite Strategy, Inc. formalized the employment agreement for Justin J. File as CEO, CFO, and Secretary.
  • The agreement details his compensation, including a $575,000 annual base salary and a 50% target annual bonus.
View Analysis

Insider Trading

SELL 2 insiders 3 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 2834)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.